In 2008, Dr. Koo earned a PhD in biomedical science from the College of Medicine at Texas A&M University. While there, his research focused on protein and genetic engineering for cancer therapeutics. Dr. Koo also earned a Bachelor of Science in biophysics in 2001 from Iowa State University.
Throughout his career, he has primarily focused on glioblastoma research. Dr. Koo holds a dual-appointment between TVMDL and the Department of Animal Science at Texas A&M University, funded by the Chancellor’s Research Initiative (CRI). The CRI was established in 2012 by Texas A&M University System Chancellor John Sharp to recruit highly-skilled researchers dedicated to the research and academic missions of Texas A&M University and Prairie View A&M University. In 2015, the CRI was expanded to include all agencies and schools within the Texas A&M University System.
In his role, Dr. Koo is part of a newly established research and development group at TVMDL that focuses on improving existing diagnostic testing, implementing new testing technologies, the creation of point of care testing devices, and the development of novel cancer therapeutics.